Pharmaceutical and Cellular Strategies in Prophylaxis and Treatment of Graft-Versus-Host Disease

E-ISSN： 1873-4286|15|17|1974-1997

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.15, Iss.17, 2009-06, pp. : 1974-1997

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Immunomodulation and pharmacological strategies in the treatment of graft-versus-host disease

By Li Minghui Sun Kai Welniak Lisbeth A Murphy William J

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 13, 2008-09 ,pp. : 2305-2316

Informa Healthcare

Access to resources Recommend Favorite

Novel therapeutics for the treatment of graft-versus-host disease

By Jacobsohn David A

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 9, 2002-09 ,pp. : 1271-1280

Informa Healthcare

Access to resources Recommend Favorite

New developments in the prophylaxis and treatment of graft versus host disease

By Simpson David

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 7, 2001-07 ,pp. : 1109-1117

Informa Healthcare

Access to resources Recommend Favorite

Chronic Graft-Versus-Host Disease

Current Pharmaceutical Design, Vol. 14, Iss. 20, 2008-07 ,pp. : 1974-1986

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of Oral Beclometasone Dipropionate in the Treatment of Gastrointestinal Graft-versus-Host Disease

By Doan Phuong L. Chao Nelson J.

Drugs, Vol. 69, Iss. 10, 2009-07 ,pp. : 1339-1350

Adis International

Access to resources Recommend Favorite